Nicki Vasquez
Director/Board Member bei ACTINOGEN MEDICAL LIMITED
Vermögen: 80 676 $ am 31.03.2024
Profil
Nicki Vasquez is an Independent Non-Executive Director at Actinogen Medical Ltd.
since 2023.
Prior to this, Dr. Vasquez served as the Chief Portfolio Strategy & Alliance Officer at Sutro Biopharma, Inc. starting in 2015.
Dr. Vasquez has also held positions at StemCells, Inc., Elan Pharmaceuticals LLC, and Perrigo Co. Plc.
Dr. Vasquez holds a doctorate degree from the University of California San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SUTRO BIOPHARMA, INC.
0,02% | 29.01.2024 | 14 279 ( 0,02% ) | 80 676 $ | 31.03.2024 |
Aktive Positionen von Nicki Vasquez
| Unternehmen | Position | Beginn |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | - |
| ACTINOGEN MEDICAL LIMITED | Director/Board Member | 01.03.2023 |
Ehemalige bekannte Positionen von Nicki Vasquez
| Unternehmen | Position | Ende |
|---|---|---|
| PERRIGO COMPANY PLC | Corporate Officer/Principal | - |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Corporate Officer/Principal | - |
Ausbildung von Nicki Vasquez
| University of California San Diego | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| ACTINOGEN MEDICAL LIMITED | Health Technology |
| PERRIGO COMPANY PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
